Gamunex-C 10% IntraVenous ImmunoGlobulin (IVIG) Single Dose Vial (25mL= 2500mg)

$445.00

– Free Next Day Delivery to Anywhere in CA and NY
– Free Same Day Delivery within 50-Mile Radius of ApoThera
– Annual Concierge Pharmacy Membership Fee: $300/year
–  Same-Day Physician Appointments
–  Generic Medicines: Just $2 per Tablet/Capsule
– Accept Credit Cards, Apple Pay and Zelle
– Concierge Pharmacy; Do NOT Accept Insurance
– Do NOT accept manufacturer coupons
 
 
1) Physicians may send E-Prescriptions (E-Scripts) to:
ApoThera
45 Post, 2nd Floor
Irvine, CA 92618
Phone: (949)387-7711
Fax:     (949)387-7712
2) Alternatively, you may schedule an appointment with one of the physicians in the ApoThera Concierge Medicine Network.
– Same-Day Physician Appointments: On-demand access to licensed physicians in the ApoThera Concierge Network.
 
 
 
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Loading Dose
– . 2,000 mg/kg (in divided doses over 2 to 4 consecutive days)
Maintenance Dose
– 1,000 mg/kg administered over 1 day every 3 weeks.
– Alternatively, administer 500 mg/kg/day for 2 consecutive days every 3 weeks.
Secondary Immunodeficiency
– 200 to 800 mg/kg IV every 3 to 4 weeks
– Dose adjusted based on monitored trough serum IgG concentrations and clinical response
Immune Thrombocytopenia (ITP)
Loading Dose
– 1,000 mg/kg/day IV for 2 consecutive days (second dose may be withheld if adequate platelet response in 24 hours)
– 400 mg/kg IV once daily for 5 consecutive days
Maintenance Dose
– 400 mg/kg IV (no more frequent than daily) as needed to maintain platelet count ≥30,000/mm3 and/or to control significant bleeding
– May increase dose if needed (range: 800 to 1,000 mg/kg).
Manufacturer: Grifols Therapeutics
 
NDC: 13533-0800-15 Category:

10% (50 mL, 5 gram) = 1 Unit

Description

Administration
– Infuse over 2 to 24 hours; administer in separate infusion line from other medications; if using primary line, flush with NS or D5W (product specific; consult product prescribing information) prior to administration- Decrease dose, rate and/or concentration of infusion in patients who may be at risk of renal failure. Decreasing the rate or stopping the infusion may help relieve some adverse effects (flushing, changes in pulse rate, changes in blood pressure).
– Epinephrine should be available during administration
– For initial treatment or in the elderly, a lower concentration and/or a slower rate of infusion should be used.
– Initial rate of administration and titration is specific to each IGIV product.
– Refrigerated product should be warmed to room temperature prior to infusion.
– Some products require filtration; refer to individual product labeling.
– Antecubital veins should be used, especially with concentrations ≥10% to prevent injection site discomfort.
Storage
– Store at 2°C to 8°C (36°F to 46°F)
– May be stored at ≤25°C (≤77°F) for up to 6 months.
Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,